News from Antibody Solutions

Roche Acquires Adheron Therapeutics and Lead Asset, SDP051
Adheron Therapeutics has been acquired by Roche in a deal worth up to $580 million. The lead asset, SDP051, a humanized monoclonal antibody targeting Cadherin-11, has completed Phase 1 of clinical dev... ...more, comments
Abs to Difficult Membrane Proteins
"Antibody Development Strategies for Difficult Membrane Proteins" will be presented by Dr John Kenney at the Discovery On Target meeting in Boston, Sept. 24, 2015 at 12:50 PM, Westin Boston Waterfront... ...more, comments
AAPS-NBC 2015 Exhibit Hall Pass
We are exhibiting at the AAPS National Biotech Conference June 8th and 9th at the Marriott Marquis in San Francisco. See below for the registration link and Promo Code for a free one-day conference... ...more, comments
Antibody Solutions to Attend AAPS National Biotechnology Conference
Antibody Solutions will be attending the AAPS National Biotechnology Conference, June 8-10, 2015 at the San Francisco Marriott Marquis. ...more, comments
Dr. Kenney Speaker at Peptalk 2015
Dr. John Kenney was a speaker for the Membrane Proteins Track, Discovery and Development of Antibody Targets. Dr. Kenney's talk was entitled "Strategies to Obtain Antibodies to Difficult Membrane Tar... ...more, comments


News-Medical.Net Antibodies News Feed

Latest Antibodies News and Research

Zika virus can persist in cerebrospinal fluid (CSF), lymph nodes and colorectal tissue of infected rhesus monkeys for weeks after the virus has been cleared from blood, urine and mucosal secretions, according to a study published online in Cell.
Posted: April 28, 2017, 6:58 pm
A research team from iMM Lisboa led by Luís Graça has found a cellular mechanism that underlies the development of autoimmune diseases.
Posted: April 28, 2017, 12:52 am
Using a unique microscope capable of illuminating living cell structures in great detail, researchers at the University of Colorado Anschutz Medical Campus have found clues into how a destructive autoimmune disease works, setting the stage for more discoveries in the future.
Posted: April 26, 2017, 3:51 pm
Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to remote or dangerous places much easier, cheaper and safer.
Posted: April 24, 2017, 12:54 pm
New findings challenge the traditional policy of replacing old strains in existing human influenza vaccines with recent variants with only minimal changes.
Posted: April 21, 2017, 11:34 pm
Monoclonal antibody-based therapies have revolutionized treatments of cancer and autoimmune diseases because of their specificity and limited toxicity.
Posted: April 21, 2017, 10:51 pm
A small, preliminary study may show promise of a new type of treatment for progressive multiple sclerosis (MS).
Posted: April 21, 2017, 3:01 am
Having a stroke damages immune cells as well as affecting the brain, research has found. The findings help explain why patients have a greater risk of catching life-threatening infections, such as pneumonia, after having a stroke.
Posted: April 21, 2017, 1:22 am
Researchers in France have developed a new method that will allow doctors to detect minute amounts of a protein called interferon-a in patient samples.
Posted: April 19, 2017, 2:08 am
Although human population studies have linked air pollution to chronic inflammation of nasal and sinus tissues, direct biological and molecular evidence for cause and effect has been scant.
Posted: April 18, 2017, 4:08 pm